Human cytomegalovirus latent infection and associated viral gene expression

Future Microbiology

Volumn 5, Issue 6, 2010, Pages 883-900

  Slobedman, Barry ^a   Cao, John Z ^a   Avdic, Selmir ^a   Webster, Bradley ^a   McAllery, Samantha ^a   Cheung, Allen K L ^a   Tan, Joanne C G ^a   Abendroth, Allison ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Herpes; Human cytomegalovirus; Latent infection; Myeloid cells; Reactivation; Viral gene expression

Indexed keywords

CELL PROTEIN; CHEMOKINE RECEPTOR; INTERLEUKIN 10; PROTEIN UL138; PROTEIN UL81 82; PROTEIN US28; UNCLASSIFIED DRUG; VIRUS DNA;

ALLOGENEIC STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; GRAFT RECIPIENT; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOCOMPROMISED PATIENT; LATENT VIRUS INFECTION; MYELOID PROGENITOR CELL; NONHUMAN; OPEN READING FRAME; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TRANSCRIPTION REGULATION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS LATENCY; VIRUS MUTATION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; VIRUS ACTIVATION; VIRUS LATENCY;

HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 77953247536     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.58     Document Type: Review

References (135)

1. Mocarski ES, Shenk T, Pass RF: Cytomegaloviruses. In: Fields Virology (5th Edition). Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2701-2772 (2007).
2. Ross DS, Dollard SC, Victor M, Sumartojo E, Cannon MJ: The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup. J. Womens Health 15(3), 224-229 (2006).
3. Pass R: Cytomegalovirus. In: Fields Virology (4th Edition). Knipe DM, Howley PM, Griffin DE et al. (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2, 2675-2705 (2001).
4. Chee MS, Bankier AT, Beck S et al.: Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154, 125-169 (1990).
5. MacCormac LP, Grundy JE: Two clinical isolates and the Toledo strain of cytomegalovirus contain endothelial cell tropic variants that are not present in the AD169, Towne, or Davis strains. J. Med. Virol. 57(3), 298-307 (1999).
6. Murphy E, Rigoutsos I, Shibuya T, Shenk TE: Reevaluation of human cytomegalovirus coding potential. Proc. Natl Acad. Sci. USA 100(23), 13585-13590 (2003).
7. Sinzger C, Schmidt K, Knapp J et al.: Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J. Gen. Virol. 80(Pt 11), 2867-2877 (1999).
8. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR: Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70(1), 78-83 (1996).
9. Prichard MN, Penfold ME, Duke GM, Spaete RR, Kemble GW: A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 11(3), 191-200 (2001).
10. Davison AJ, Dolan A, Akter P et al.: The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J. Gen. Virol. 84(Pt 1), 17-28 (2003).
11. Dolan A, Cunningham C, Hector RD et al.: Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85(Pt 5), 1301-1312 (2004).
12. Murphy E, Shenk T: Human cytomegalovirus genome. Curr. Top. Microbiol. Immunol. 325, 1-19 (2008).
13. Murphy E, Yu D, Grimwood J et al.: Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl Acad. Sci. USA 100(25), 14976-14981 (2003).
14. Dunn W, Chou C, Li H et al.: Functional profiling of a human cytomegalovirus genome. Proc. Natl Acad. Sci. USA 100(24), 14223-14228 (2003).
15. Yu D, Silva MC, Shenk T: Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl Acad. Sci. USA 100(21), 12396-12401 (2003).
16. Mocarski ES, Courcelle CT: Cytomegaloviruses and their replication. In: Fields Virology (4th Edition), Volume 2. Knipe DM, Howley PM, Griffin DE et al. (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2629-2673 (2001).
17. Adler SP: Transfusion-associated cytomegalovirus infections. Rev. Infect. Dis. 5(6), 977-993 (1983).
18. Prince AM, Szmuness W, Millian SJ, David DS: A serologic study of cytomegalovirus infections associated with blood transfusions. N. Engl. J. Med. 284(20), 1125-1131 (1971).
19. Tolpin MD, Stewart JA, Warren D et al.: Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. J. Pediatrics 107(6), 953-956 (1985).
20. de Graan-Hentzen YC, Gratama JW, Mudde GC et al.: Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 29(9), 757-760 (1989).
21. De Witte T, Schattenberg A, Van Dijk BA et al.: Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors. Transplantation 50(6), 964-968 (1990).
22. Gilbert GL, Hayes K, Hudson IL, James J: Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1(8649), 1228-1231 (1989).
23. Winston DJ, Ho WG, Howell CL et al.: Cytomegalovirus infections associated with leukocyte transfusions. Ann. Intern. Med. 93(5), 671-675 (1980).
24. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG: Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J. Pediatrics 98(2), 281-287 (1981).
25. Jordan MC: Latent infection and the elusive cytomegalovirus. Rev. Infect. Dis. 5(2), 205-215 (1983).
26. Einhorn L, Ost A: Cytomegalovirus infection of human blood cells. J. Infect. Dis. 149(2), 207-214 (1984).
27. Dankner WM, McCutchan JA, Richman DD, Hirata K, Spector SA: Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J. Infect. Dis. 161(1), 31-36 (1990).
28. Bevan IS, Daw RA, Day PJ, Ala FA, Walker MR: Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population. Br. J. Haematol. 78(1), 94-99 (1991).
29. Larsson S, Soderberg-Naucler C, Wang FZ, Moller E: Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 38(3), 271-278 (1998).
30. Stanier P, Taylor DL, Kitchen AD, Wales N, Tryhorn Y, Tyms AS: Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. BMJ 299(6704), 897-898 (1989).
31. Taylor-Wiedeman J, Hayhurst GP, Sissons JG, Sinclair JH: Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J. Gen. Virol. 74(Pt 2), 265-268 (1993).
32. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72(Pt 9), 2059-2064 (1991).
33. Rice GP, Schrier RD, Oldstone MB: Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl Acad. Sci. USA 81(19), 6134-6138 (1984).
34. Smith MS, Bentz GL, Alexander JS, Yurochko AD: Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 78(9), 4444-4453 (2004).
35. Taylor-Wiedeman J, Sissons P, Sinclair J: Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68(3), 1597-1604 (1994).
36. Bolovan-Fritts CA, Mocarski ES, Wiedeman JA: Peripheral blood CD14+ cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93(1), 394-398 (1999).
37. Decker L, Klaman LD, Thorley-Lawson DA: Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol. 70, 3286 (1996).
38. Clarke P, Beer T, Cohrs R, Gilden DH: Configuration of latent varicella-zoster virus DNA. J. Virol. 69(12), 8151-8154 (1995).
39. Gardella T, Medveczky P, Sairenji T, Mulder C: Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50(1), 248-254 (1984).
40. Rock DL, Fraser NW: Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 302(5908), 523-525 (1983).
41. Whitelaw DM: Observations on human monocyte kinetics after pulse labeling. Cell Tissue Kinet. 5(4), 311-317 (1972).
42. Minton EJ, Tysoe C, Sinclair JH, Sissons JG: Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68(6), 4017-4021 (1994).
43. Metcalf D: Hemopoietic growth factors and marrow transplantation: an overview. Transplant. Proc. 21(1 Pt 3), 2932-2933 (1989).
44. Hahn G, Jores R, Mocarski ES: Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl Acad. Sci. USA 95(7), 3937-3942 (1998).
45. Ardavin C, Martinez del Hoyo G, Martin P et al.: Origin and differentiation of dendritic cells. Trends Immunol. 22(12), 691-700 (2001).
46. Geissmann F: The origin of dendritic cells. Nat. Immunol. 8(6), 558-560 (2007).
47. Goodrum F, Jordan CT, Terhune SS, High K, Shenk T: Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 104(3), 687-695 (2004).
48. Goodrum FD, Jordan CT, High K, Shenk T: Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc. Natl Acad. Sci. USA 99(25), 16255-16260 (2002).
49. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC: Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80(1), 170-178 (1992).
50. Movassagh M, Gozlan J, Senechal B, Baillou C, Petit JC, Lemoine FM: Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood 88(4), 1277-1283 (1996).
51. Zhuravskaya T, Maciejewski JP, Netski DM, Bruening E, Mackintosh FR, St Jeor SC: Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency. Blood 90(6), 2482-2491 (1997).
52. Kondo K, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl Acad. Sci. USA 91(25), 11879-11883 (1994).
53. Kondo K, Xu J, Mocarski ES: Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl Acad. Sci. USA 93(20), 11137-11142 (1996).
54. Cheung AK, Gottlieb DJ, Plachter B et al.: The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency. Blood 114(19), 4128-4137 (2009).
55. Cheung AK, Abendroth A, Cunningham AL, Slobedman B: Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood 108(12), 3691-3699 (2006).
56. Mendelson M, Monard S, Sissons P, Sinclair J: Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 77(Pt 12), 3099-3102 (1996).
57. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH: Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl Acad. Sci. USA 102(11), 4140-4145 (2005a).
58. Slobedman B, Mocarski ES: Quantitative analysis of latent human cytomegalovirus. J. Virol. 73(6), 4806-4812 (1999).
59. Asahara T, Murohara T, Sullivan A et al.: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302), 964-967 (1997).
60. Prater DN, Case J, Ingram DA, Yoder MC: Working hypothesis to redefine endothelial progenitor cells. Leukemia 21(6), 1141-1149 (2007).
61. Yoder MC, Mead LE, Prater D et al.: Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/ progenitor cell principals. Blood 109(5), 1801-1809 (2007).
62. Hendrix MG, Dormans PH, Kitslaar P, Bosman F, Bruggeman CA: The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am. J. Pathol. 134(5), 1151-1157 (1989).
63. Hendrix MG, Daemen M, Bruggeman CA: Cytomegalovirus nucleic acid distribution within the human vascular tree. Am. J. Pathol. 138(3), 563-567 (1991).
64. Hendrix MG, Salimans MM, van Boven CP, Bruggeman CA: High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136(1), 23-28 (1990).
65. Hendrix RM, Wagenaar M, Slobbe RL, Bruggeman CA: Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J. Clin. Pathol. 50(1), 59-63 (1997).
66. Pampou S, Gnedoy SN, Bystrevskaya VB et al.: Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta. Virchows Archiv. 436(6), 539-552 (2000).
67. Reeves MB, Coleman H, Chadderton J, Goddard M, Sissons JG, Sinclair JH: Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo. J. Gen. Virol. 85(Pt 11), 3337-3341 (2004).
68. Jarvis MA, Nelson JA: Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J. Virol. 81(5), 2095-2101 (2007).
69. Seckert CK, Renzaho A, Tervo HM et al.: Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J. Virol. 83(17), 8869-8884 (2009).
70. Hertel L, Lacaille VG, Strobl H, Mellins ED, Mocarski ES: Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 77(13), 7563-7574 (2003).
71. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA: Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65(12), 6581-6588 (1991).
72. Riegler S, Hebart H, Einsele H, Brossart P, Jahn G, Sinzger C: Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 81(Pt 2), 393-399 (2000).
73. Sinzger C, Eberhardt K, Cavignac Y et al.: Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules. J. Gen. Virol. 87(Pt 7), 1853-1862 (2006).
74. Weinshenker BG, Wilton S, Rice GP: Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J. Immunol. 140(5), 1625-1631 (1988).
75. Lathey JL, Spector SA: Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 65(11), 6371-6375 (1991).
76. Sinzger C, Plachter B, Grefte A, The TH, Jahn G: Tissue macrophages are infected by human cytomegalovirus in vivo. J. Infect. Dis. 173(1), 240-245 (1996).
77. Soderberg-Naucler C, Fish KN, Nelson JA: Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91(1), 119-126 (1997).
78. Soderberg-Naucler C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA: Reactivation of latent human cytomegalovirus in CD14+ monocytes is differentiation dependent. J. Virol. 75(16), 7543-7554 (2001).
79. Sinclair J, Sissons P: Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 87(Pt 7), 1763-1779 (2006).
80. Goodrum F, Reeves M, Sinclair J, High K, Shenk T: Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110(3), 937-945 (2007).
81. Reeves MB, Lehner PJ, Sissons JG, Sinclair JH: An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J. Gen. Virol. 86(Pt 11), 2949-2954 (2005b).
82. Kent JR, Kang W, Miller CG, Fraser NW: Herpes simplex virus latency-associated transcript gene function. J. Neurovirol. 9(3), 285-290 (2003).
83. Knipe DM, Cliffe A: Chromatin control of herpes simplex virus lytic and latent infection. Nat. Rev. Microbiol. 6(3), 211-221 (2008).
84. Cohen JI, Cox E, Pesnicak L, Srinivas S, Krogmann T: The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J. Virol. 78(21), 11833-11840 (2004).
85. Cohen JI, Krogmann T, Pesnicak L, Ali MA: Absence or overexpression of the varicella-zoster virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces VZV latency in a rodent model. J. Virol. 81(4), 1586-1591 (2007).
86. Cohen JI, Krogmann T, Ross JP, Pesnicak L, Prikhod'ko EA: Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency. J. Virol. 79(11), 6969-6975 (2005).
87. Beisser PS, Laurent L, Virelizier JL, Michelson S: Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes. J. Virol. 75(13), 5949-5957 (2001).
88. Reeves M, Sinclair J: Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J. Gen. Virol. 91(Pt 3), 599-604 (2010).
89. Khaiboullina SF, Maciejewski JP, Crapnell K et al.: Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br. J. Haematol. 126(3), 410-417 (2004).
90. Kondo K, Mocarski ES: Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand. J. Infect. Dis. Suppl. 99, 63-67 (1995).
91. Lunetta JM, Wiedeman JA: Latency-associated sense transcripts are expressed during in vitro human cytomegalovirus productive infection. Virology 278(2), 467-476 (2000).
92. Bego M, Maciejewski J, Khaiboullina S, Pari G, St Jeor S: Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J. Virol. 79(17), 11022-11034 (2005).
93. Landini MP, Lazzarotto T, Xu J, Geballe AP, Mocarski ES: Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. Biol. Blood Marrow Transplant 6(2), 100-108 (2000).
94. White KL, Slobedman B, Mocarski ES: Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J. Virol. 74(19), 9333-9337 (2000).
95. Jenkins C, Abendroth A, Slobedman B: A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J. Virol. 78(3), 1440-1447 (2004).
96. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S: Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl Acad. Sci. USA 97(4), 1695-1700 (2000a).
97. Lockridge KM, Zhou SS, Kravitz RH et al.: Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268(2), 272-280 (2000).
98. Jenkins C, Garcia W, Abendroth A, Slobedman B: Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. Virology 370(2), 285-294 (2008). (Pubitemid 350192559)
99. Jenkins C, Garcia W, Godwin MJ et al.: Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. J. Virol. 82(7), 3736-3750 (2008). (Pubitemid 351429949)
100. Chang WL, Baumgarth N, Yu D, Barry PA: Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol. 78(16), 8720-8731 (2004).
101. Raftery MJ, Wieland D, Gronewald S, Kraus AA, Giese T, Schonrich G: Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J. Immunol. 173(5), 3383-3391 (2004).
102. Spencer JV, Cadaoas J, Castillo PR, Saini V, Slobedman B: Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology 374(1), 164-169 (2008).
103. Jaworowski A, Cheng WJ, Westhorpe CL, Abendroth A, Crowe SM, Slobedman B: Enhanced monocyte Fc phagocytosis by a homologue of interleukin-10 encoded by human cytomegalovirus. Virology 391(1), 20-24 (2009).
104. Spencer JV, Lockridge KM, Barry PA et al.: Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. [erratum appears in J. Virol. 76(7), 3585 (2002)]. J. Virol. 76(3), 1285-1292 (2002).
105. Jones BC, Logsdon NJ, Josephson K, Cook J, Barry PA, Walter MR: Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc. Natl Acad. Sci. USA 99(4), 9404-9409 (2002).
106. Petrucelli A, Rak M, Grainger L, Goodrum F: Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus. J. Virol. 83(11), 5615-5629 (2009).
107. Slobedman B, Mocarski ES, Arvin AM, Mellins ED, Abendroth A: Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood 100(8), 2867-2873 (2002).
108. Bresnahan WA, Shenk TE: UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc. Natl Acad. Sci. USA 97(26), 14506-14511 (2000).
109. Reeves M, Sinclair J: Aspects of human cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325, 297-313 (2008).
110. Welch AR, McGregor LM, Gibson W: Cytomegalovirus homologs of cellular G protein-coupled receptor genes are transcribed. J. Virol. 65(7), 3915-3918 (1991).
111. Zipeto D, Bodaghi B, Laurent L, Virelizier JL, Michelson S: Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types. J. Gen. Virol. 80(Pt 3), 543-547 (1999).
112. Vieira J, Schall TJ, Corey L, Geballe AP: Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J. Virol. 72(10), 8158-8165 (1998).
113. Gao JL, Murphy PM: Human cytomegalovirus open reading frame US28 encodes a functional b chemokine receptor. J. Biol. Chem. 269(46), 28539-28542 (1994).
114. Kuhn DE, Beall CJ, Kolattukudy PE: The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem. Biophys. Res. Commun. 211(1), 325-330 (1995).
115. Kledal TN, Rosenkilde MM, Schwartz TW: Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett. 441(2), 209-214 (1998).
116. Patterson BK, Landay A, Andersson J et al.: Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am. J. Pathol. 153(2), 481-490 (1998). (Pubitemid 28373659)
117. Cohrs RJ, Wischer J, Essman C, Gilden DH: Characterization of varicella-zoster virus gene 21 and 29 proteins in infected cells. J. Virol. 76(14), 7228-7238 (2002).
118. Debrus S, Sadzot-Delvaux C, Nikkels AF, Piette J, Rentier B: Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J. Virol. 69(5), 3240-3245 (1995).
119. Jin L, Scherba G: Expression of the pseudorabies virus latency-associated transcript gene during productive infection of cultured cells. J. Virol. 73(12), 9781-9788 (1999).
120. Lear AL, Rowe M, Kurilla MG et al.: The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J. Virol. 66(12), 7461-7468 (1992).
121. Schaefer BC, Strominger JL, Speck SH: Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl Acad. Sci. USA 92(23), 10565-10569 (1995).
122. Spivack JG, Fraser NW: Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J. Virol. 61(12), 3841-3847 (1987).
123. Xia D, Srinivas S, Sato H, Pesnicak L, Straus SE, Cohen JI: Varicella-zoster virus open reading frame 21, which is expressed during latency, is essential for virus replication but dispensable for establishment of latency. J. Virol. 77(2), 1211-1218 (2003).
124. Xia D, Straus SE: Transcript mapping and transregulatory behavior of varicella-zoster virus gene 21, a latency-associated gene. Virology 258(2), 304-313 (1999).
125. Kang W, Mukerjee R, Fraser NW: Establishment and maintenance of HSV latent infection is mediated through correct splicing of the LAT primary transcript. Virology 312(1), 233-244 (2003).
126. Sawtell NM, Thompson RL: Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J. Virol. 66(4), 2157-2169 (1992).
127. Thompson RL, Sawtell NM: The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J. Virol. 71(7), 5432-5440 (1997).
128. Perng GC, Dunkel EC, Geary PA et al.: The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J. Virol. 68(12), 8045-8055 (1994).
129. Perng GC, Slanina SM, Yukht A et al.: A herpes simplex virus type 1 latency-associated transcript mutant with increased virulence and reduced spontaneous reactivation. J. Virol. 73(2), 920-929 (1999).
130. Jin L, Peng W, Perng GC et al.: Identification of herpes simplex virus type 1 latency-associated transcript sequences that both inhibit apoptosis and enhance the spontaneous reactivation phenotype. J. Virol. 77(11), 6556-6561 (2003).
131. Perng GC, Jones C, Ciacci-Zanella J et al.: Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287(5457), 1500-1503 (2000).
132. Ahmed M, Lock M, Miller CG, Fraser NW: Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J. Virol. 76(2), 717-729 (2002).
133. Jones C, Inman M, Peng W et al.: The herpes simplex virus type 1 locus that encodes the latency-associated transcript enhances the frequency of encephalitis in male BALB/c mice. J. Virol. 79(22), 14465-14469 (2005).
134. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT: RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons. Science 235(4792), 1056-1059 (1987).
135. Mocarski ES, Hahn G, White KL et al.: Myeloid cell recruitment and function in pathogenesis and latency. In: Cytomegaloviruses: Molecular Biology and Immunology. Reddehase MJ (Ed.). Caister Academic Press, Hethersett, Norfolk, UK, 465-482 (2006).